person · Reporting owner

NAUMANN-ETIENNE RUEDIGER

Disclosed activity across 2 companies

Tapewire entity: 116985
SEC CIK: 0001219636

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
IRIDEX CORPIRIX · Entity 7882	Director	July 23, 2019	July 25, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

IRIDEX CORP

Report date July 23, 2019 · Filed July 25, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	86,872	Ending reported balance After 2019-07-23 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2019-07-23 · Grant · Acquired 11,204 · Balance 84,872 F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders. Row 2 · 2019-07-23 · Grant · Acquired 2,000 · Balance 86,872 F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	23,000	Reported balance Holding disclosure · report date 2019-07-23 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 23,000 F2: The shares are owned by the Naumann-Etienne Foundation, over which the Report Person may be deemed to share voting and dispositive power as a result of his position as president. The Reporting Person disclaims beneficial ownership of the shares owned by Naumann-Etienne Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders.

F2: The shares are owned by the Naumann-Etienne Foundation, over which the Report Person may be deemed to share voting and dispositive power as a result of his position as president. The Reporting Person disclaims beneficial ownership of the shares owned by Naumann-Etienne Foundation.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Varex Imaging Corp

Report date February 09, 2023 · Filed February 13, 2023

Section 16 reporting ended · disclosed 2023-02-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	48,346	Ending reported balance After 2023-02-09 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2023-02-09 · Exercise / conversion · Acquired 8,471 · Balance 29,846 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Row 2 · 2023-02-09 · Exercise / conversion · Acquired 9,462 · Balance 39,308 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Row 3 · 2023-02-09 · Exercise / conversion · Acquired 9,038 · Balance 48,346 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2023-02-09 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-02-09 · Exercise / conversion · Disposed 8,471 · Balance 0 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vested on February 13, 2021. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2023-02-09 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-02-09 · Exercise / conversion · Disposed 9,462 · Balance 0 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3: These Deferred Stock Units vested on February 10, 2022. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2023-02-09 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-02-09 · Exercise / conversion · Disposed 9,038 · Balance 0 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4: These Deferred Stock Units vested on February 9, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2: These Deferred Stock Units vested on February 13, 2021. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

F3: These Deferred Stock Units vested on February 10, 2022. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

F4: These Deferred Stock Units vested on February 9, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 09, 2023 Filed Feb 13, 2023 17:25 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	9,038	$0.00	$0.00	Disclosure SEC source: 0001681622-23-000026 · wf-form4_167632711479999.xml · derivative · entry 6 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Deferred Stock Units vested on February 9, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer. F4 · derivative.expiration_date: These Deferred Stock Units vested on February 9, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer. Read SEC document
February 09, 2023 Filed Feb 13, 2023 17:25 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	9,462	$0.00	$0.00	Disclosure SEC source: 0001681622-23-000026 · wf-form4_167632711479999.xml · derivative · entry 5 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 10, 2022. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 10, 2022. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer. Read SEC document
February 09, 2023 Filed Feb 13, 2023 17:25 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	8,471	$0.00	$0.00	Disclosure SEC source: 0001681622-23-000026 · wf-form4_167632711479999.xml · derivative · entry 4 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,471 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vested on February 13, 2021. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer. F2 · derivative.expiration_date: These Deferred Stock Units vested on February 13, 2021. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer. Read SEC document
February 09, 2023 Filed Feb 13, 2023 17:25 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	9,038	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-23-000026 · wf-form4_167632711479999.xml · nonDerivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 09, 2023 Filed Feb 13, 2023 17:25 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	9,462	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-23-000026 · wf-form4_167632711479999.xml · nonDerivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 09, 2023 Filed Feb 13, 2023 17:25 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	8,471	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-23-000026 · wf-form4_167632711479999.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
August 24, 2022 Filed Nov 9, 2022 19:00 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	5,000	$21.60	$108,000.00	Disclosure SEC source: 0001681622-22-000083 · wf-form4_166803838636960.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,375 F1 · date: This Form 4 is being filed late due to an inadvertent administrative error. F2 · price: All individual shares were sold at a price of $21.60 Read SEC document
June 06, 2022 Filed Jun 8, 2022 17:30 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	5,207	$22.62	$117,782.34	Disclosure SEC source: 0001681622-22-000056 · wf-form4_165472378253949.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,375 F1 · price: All individual shares were sold at a price of $22.62 Read SEC document
February 14, 2022 Filed Feb 14, 2022 19:17 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	7,010	$0.00	$0.00	Disclosure SEC source: 0001681622-22-000024 · wf-form4_164488420854201.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 7,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document
February 14, 2022 Filed Feb 14, 2022 19:17 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Shares	7,010	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-22-000024 · wf-form4_164488420854201.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 10, 2022 Filed Feb 14, 2022 19:17 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	9,038	$0.00	$0.00	Disclosure SEC source: 0001681622-22-000024 · wf-form4_164488420854201.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,038 Underlying: Common Stock · 9,038 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
March 02, 2021 Filed Mar 4, 2021 18:15 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	4,264	$23.89	$101,866.96	Disclosure SEC source: 0001681622-21-000052 · wf-form4_161489972657427.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,572 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.85 to $23.90. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document
February 11, 2021 Filed Feb 16, 2021 20:04 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	5,929	$0.00	$0.00	Disclosure SEC source: 0001681622-21-000024 · wf-form4_161352387236964.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 15, 2019. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 15, 2021. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 15, 2019. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 15, 2021. Read SEC document
February 11, 2021 Filed Feb 16, 2021 20:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	9,462	$0.00	$0.00	Disclosure SEC source: 0001681622-21-000024 · wf-form4_161352387236964.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,462 Underlying: Common Stock · 9,462 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2024 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2024 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
February 11, 2021 Filed Feb 16, 2021 20:04 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	5,929	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-21-000024 · wf-form4_161352387236964.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 14, 2020 Filed Feb 18, 2020 20:01 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	7,078	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000017 · wf-form4_158207409522912.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. F3 · derivative.expiration_date: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. Read SEC document
February 14, 2020 Filed Feb 18, 2020 20:01 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Shares	7,078	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-20-000017 · wf-form4_158207409522912.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 13, 2020 Filed Feb 18, 2020 20:01 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	8,471	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000017 · wf-form4_158207409522912.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,471 Underlying: Common Stock · 8,471 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
July 23, 2019 Filed Jul 25, 2019 22:53 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0001209191-19-043262 · doc4.xml · nonDerivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,872 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders. Read SEC document
July 23, 2019 Filed Jul 25, 2019 22:53 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	11,204	$0.00	$0.00	Disclosure SEC source: 0001209191-19-043262 · doc4.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,872 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders. Read SEC document
February 14, 2019 Filed Feb 19, 2019 19:57 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	7,010	$0.00	$0.00	Disclosure SEC source: 0001681622-19-000026 · wf-form4_155062425934406.xml · derivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,010 Underlying: Common Stock · 7,010 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:31 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	6,358	$0.00	$0.00	Disclosure SEC source: 0001681622-19-000010 · wf-form4_155019066530169.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019. F2 · derivative.expiration_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019. Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:31 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	6,358	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-19-000010 · wf-form4_155019066530169.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
June 13, 2018 Filed Jun 16, 2018 00:12 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0001704739-18-000030 · edgar.xml · nonDerivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,668 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 13, 2019 or the date of the Issuer's next annual meeting of stockholders. Read SEC document
June 13, 2018 Filed Jun 16, 2018 00:12 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	5,690	$0.00	$0.00	Disclosure SEC source: 0001704739-18-000030 · edgar.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,668 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 13, 2019 or the date of the Issuer's next annual meeting of stockholders. Read SEC document
May 30, 2018 Filed May 31, 2018 17:58 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	1,500	$37.96	$56,941.50	Disclosure SEC source: 0001214659-18-004193 · marketforms-42154.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,471 Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:56 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	5,929	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001434 · marketforms-41082.xml · derivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,929 Underlying: Common Stock · 5,929 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death. Read SEC document
February 13, 2018 Filed Feb 15, 2018 19:31 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	5,207	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001335 · marketforms-41027.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,207 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Deferred Stock Units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The Deferred Stock Units fully vested on February 13, 2016. Pursuant to the terms of the applicable grant agreement, payment, in the form of shares of common stock, became due on February 13, 2018. F2 · derivative.expiration_date: The Deferred Stock Units fully vested on February 13, 2016. Pursuant to the terms of the applicable grant agreement, payment, in the form of shares of common stock, became due on February 13, 2018. Read SEC document
February 13, 2018 Filed Feb 15, 2018 19:31 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	5,207	$36.21	$188,545.47	Disclosure SEC source: 0001214659-18-001335 · marketforms-41027.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Deferred Stock Units convert into common stock on a one-for-one basis. Read SEC document
June 14, 2017 Filed Jun 15, 2017 23:13 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0001704739-17-000005 · edgar.xml · nonDerivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,834 F1 · shares: The restricted stock shall vest with respect to one hundred percent (100%) of the shares on June 14, 2018. Read SEC document
June 14, 2017 Filed Jun 15, 2017 23:13 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	4,301	$0.00	$0.00	Disclosure SEC source: 0001704739-17-000005 · edgar.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,834 F1 · shares: The restricted stock shall vest with respect to one hundred percent (100%) of the shares on June 14, 2018. Read SEC document
June 14, 2017 Filed Jul 5, 2017 23:11 UTC	IRIDEX CORP IRIX · Entity 7882	GrantCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0001704739-17-000011 · edgar.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,990 F1 · shares: The restricted stock shall vest with respect to one hundred percent (100%) of the shares on June 14, 2018. Read SEC document
February 21, 2017 Filed Feb 23, 2017 18:21 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	5,764	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001331 · marketforms-38013.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,764 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Deferred Stock Units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The Deferred Stock Units were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F2 · derivative.expiration_date: The Deferred Stock Units were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. Read SEC document
February 21, 2017 Filed Feb 23, 2017 18:21 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	5,764	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001331 · marketforms-38013.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Deferred Stock Units convert into common stock on a one-for-one basis. Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:31 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	7,079	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001257 · marketforms-37985.xml · derivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,408 Underlying: Common Stock · 7,079 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 16, 2017. Vested shares will be delivered to the reporting person the earlier of four years from the grant date or termination date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 16, 2017. Vested shares will be delivered to the reporting person the earlier of four years from the grant date or termination date. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:02 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000580 · marketforms-37687.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F4 · derivative.exercise_date: These DSUs vest in four equal quarterly installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These DSUs vest in four equal quarterly installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F1 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:02 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000580 · marketforms-37687.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · derivative.exercise_date: These DSUs vest in four equal quarterly installments beginning on February 13, 2016. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These DSUs vest in four equal quarterly installments beginning on February 13, 2016. Vested shares will be delivered to the reporting person upon vest date. F1 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:02 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000580 · marketforms-37687.xml · derivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F2 · derivative.exercise_date: These DSUs vest in four equal quarterly installments beginning on February 21, 2015. Vested shares will be delivered to the reporting person upon vest date. F2 · derivative.expiration_date: These DSUs vest in four equal quarterly installments beginning on February 21, 2015. Vested shares will be delivered to the reporting person upon vest date. F1 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:00 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	6,358	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000911 · marketforms-37814.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 6,358 shares Expires 2020-02-12 F1 · derivative.exercise_price: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F4 · derivative.exercise_date: These DSUs vest one year in four (4) equal quarterly installments over a 12 month period beginning February 12, 2016. Vested shares will be delivered the earlier of three (3) years from February 12, 2016 or termination date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:00 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	5,207	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000911 · marketforms-37814.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,207 shares Expires 2019-02-13 F1 · derivative.exercise_price: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · derivative.exercise_date: These DSUs were fully vested on February 13, 2016. Vested shares will be delivered the earlier of three (3) years from February 13, 2015 or termination date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:00 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	5,764	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000911 · marketforms-37814.xml · derivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,764 shares Expires 2018-02-21 F1 · derivative.exercise_price: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F2 · derivative.exercise_date: These DSUs were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
September 07, 2016 Filed Sep 7, 2016 23:47 UTC	IRIDEX CORP IRIX · Entity 7882	SaleCommon Stock	7,000	$14.76	$103,332.60	Disclosure SEC source: 0001261380-16-000110 · edgar.xml · nonDerivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,433 F2 · price: The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $14.750 to $14.77365 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document
September 02, 2016 Filed Sep 7, 2016 23:47 UTC	IRIDEX CORP IRIX · Entity 7882	SaleCommon Stock	2,513	$14.73	$37,016.49	Disclosure SEC source: 0001261380-16-000110 · edgar.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,433 F1 · price: The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $14.22 to $14.8606 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.